bST & Milk: Benefit or Bane?

Anya M. McGuirk and Harry Kaiser

Choices: The Magazine of Food, Farm, and Resource Issues, 1991, vol. 06, issue 01, 5

Abstract: Bovine somatotropin (bST), a genetically engineered hormone for dairy cows that could increase milk yields by as much as 10 to 25 percent, is currently in the final phases of the U.S. Food and Drug Administration (FDA) approval process. Anticipating its ultimate approval economists and industry analysts have concentrated their studies on the potential impact of bST on individual farmers, as well as on the dairy industry as a whole-the supply effects. In contrast, demand aspects have been largely ignored. But they shouldn't be because consumer backlash to bST in terms of lower demand could be substantial.

Keywords: Agricultural and Food Policy; Food Consumption/Nutrition/Food Safety (search for similar items in EconPapers)
Date: 1991
References: Add references at CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
https://ageconsearch.umn.edu/record/130670/files/McGuirkandKaiser.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:aaeach:130670

DOI: 10.22004/ag.econ.130670

Access Statistics for this article

More articles in Choices: The Magazine of Food, Farm, and Resource Issues from Agricultural and Applied Economics Association Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().